PE20080070A1 - Derivados de indolobenzazepina fusionados a ciclopropilo como inhibidores de la polimerasa ns5b del virus de la hepatitis c - Google Patents

Derivados de indolobenzazepina fusionados a ciclopropilo como inhibidores de la polimerasa ns5b del virus de la hepatitis c

Info

Publication number
PE20080070A1
PE20080070A1 PE2007000585A PE2007000585A PE20080070A1 PE 20080070 A1 PE20080070 A1 PE 20080070A1 PE 2007000585 A PE2007000585 A PE 2007000585A PE 2007000585 A PE2007000585 A PE 2007000585A PE 20080070 A1 PE20080070 A1 PE 20080070A1
Authority
PE
Peru
Prior art keywords
alkyl
hepatitis
cyclopropyl
virus
inhibitors
Prior art date
Application number
PE2007000585A
Other languages
English (en)
Inventor
John A Bender
Min Ding
Robert G Gentles
Piyasena Hewawasam
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38512732&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20080070(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of PE20080070A1 publication Critical patent/PE20080070A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE REFIERE A COMPUESTOS DE DERIVADOS DE INDOLOBENZAZEPINA FUSIONADOS A CICLOPROPILO DE FORMULA (I) DONDE R1 ES CO2R5 O CONR6R7, DONDE R5 ES H O ALQUILO(C1-C6); R6 ES H, ALQUILO(C1-C6), ALQUIL(C1-C6)SO2, CICLOALQUIL(C3-C7)SO2, ENTRE OTROS; R7 ES H O ALQUILO(C1-C6); R2 ES UN COMPUESTO DE FORMULA (i) O (ii), DONDE R8 ES H, ALQUILO(C1-C6), CICLOALQUILO(C3-C7), AMINOCARBONILO, ENTRE OTROS; R3 ES H, HALO, ALQUILO(C1-C6), OH, ENTRE OTROS; R4 ES CICLOALQUILO(C3-C7). SON COMPUESTOS PREFERIDOS: (+/-)-8-CICLOHEXIL-N-(METILSULFONIL)-1,1a,2,12b-TETRAHIDRO-11-METOXI-1a-(3-METIL-3,8-DIAZABICICLO[3.2.1]OCTANO-8-CARBONIL)CICLOPROP[d]INDOLO[2,1-a][2]BENZAZEPINA-5-CARBOXAMIDA, (+/-)-8-CICLOHEXIL-N-(ETILSULFONIL)-1,1a,2,12b-TETRAHIDRO-11-METOXI-1a-(3-METIL-3,8-DIAZABICICLO[3.2.1]OCTANO-8-CARBONIL)CICLOPROP[d]INDOLO[2,1-a][2]BENZAZEPINA-5-CARBOXAMIDA, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE LA POLIMERASA NS5B DEL VIRUS DE LA HEPATITIS C SIENDO UTILES EN EL TRATAMIENTO DE LA INFECCION DE LA HEPATITIS C
PE2007000585A 2006-05-17 2007-05-15 Derivados de indolobenzazepina fusionados a ciclopropilo como inhibidores de la polimerasa ns5b del virus de la hepatitis c PE20080070A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US80112506P 2006-05-17 2006-05-17
US80200506P 2006-05-19 2006-05-19
US85208406P 2006-10-16 2006-10-16
US89475707P 2007-03-14 2007-03-14

Publications (1)

Publication Number Publication Date
PE20080070A1 true PE20080070A1 (es) 2008-03-10

Family

ID=38512732

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000585A PE20080070A1 (es) 2006-05-17 2007-05-15 Derivados de indolobenzazepina fusionados a ciclopropilo como inhibidores de la polimerasa ns5b del virus de la hepatitis c

Country Status (25)

Country Link
US (1) US7456166B2 (es)
EP (1) EP2024375B1 (es)
JP (1) JP5284952B2 (es)
KR (1) KR101417145B1 (es)
AR (1) AR061008A1 (es)
AT (1) ATE501156T1 (es)
AU (1) AU2007253998B2 (es)
BR (1) BRPI0711821A2 (es)
CA (1) CA2651690C (es)
CY (1) CY1111526T1 (es)
DE (1) DE602007013036D1 (es)
DK (1) DK2024375T3 (es)
EA (1) EA015286B1 (es)
HK (1) HK1122814A1 (es)
HR (1) HRP20110194T1 (es)
IL (1) IL195025A (es)
MX (1) MX2008014435A (es)
NO (1) NO341663B1 (es)
NZ (1) NZ572555A (es)
PE (1) PE20080070A1 (es)
PL (1) PL2024375T3 (es)
SI (1) SI2024375T1 (es)
TW (1) TWI401244B (es)
WO (1) WO2007136982A1 (es)
ZA (1) ZA200809548B (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1688420A4 (en) * 2003-11-19 2008-10-22 Japan Tobacco Inc 5-5 LOW-CONDENSED HETEROCYCLIC COMPOUND AND THEIR USE AS HCV POLYMERASE INHIBITOR
US20070049593A1 (en) * 2004-02-24 2007-03-01 Japan Tobacco Inc. Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
US7659263B2 (en) 2004-11-12 2010-02-09 Japan Tobacco Inc. Thienopyrrole compound and use thereof as HCV polymerase inhibitor
US7521443B2 (en) * 2006-05-17 2009-04-21 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
US7456167B2 (en) * 2006-05-25 2008-11-25 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
US7541351B2 (en) * 2007-01-11 2009-06-02 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US7541352B2 (en) * 2007-02-02 2009-06-02 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US7517872B2 (en) * 2007-02-22 2009-04-14 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US7998951B2 (en) * 2007-03-05 2011-08-16 Bristol-Myers Squibb Company HCV NS5B inhibitors
CN101679437B (zh) 2007-03-13 2013-04-17 百时美施贵宝公司 环丙基稠合的吲哚并苯并氮杂*hcv ns5b抑制剂
US7521444B2 (en) * 2007-03-14 2009-04-21 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US7547690B2 (en) * 2007-03-14 2009-06-16 Bristol-Myers Squibb Company Compounds for the treatment of Hepatitis C
US7541353B2 (en) * 2007-03-14 2009-06-02 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US7538102B2 (en) * 2007-03-14 2009-05-26 Bristol-Myers Squibb Company Compounds for the treatment of Hepatitis C
US7538103B2 (en) * 2007-03-15 2009-05-26 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
NZ580917A (en) 2007-05-04 2012-06-29 Vertex Pharma Combinations of protease inhibitors such as VX-950 and polymerase inhibitors for the treatment of HCV infection
US7652004B2 (en) * 2007-08-09 2010-01-26 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US8143243B2 (en) * 2007-08-09 2012-03-27 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US7642251B2 (en) * 2007-08-09 2010-01-05 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
SI2209789T1 (sl) * 2007-11-20 2012-06-29 Bristol Myers Squibb Co Ciklopropil zliti indolobenzazepin hcv ns5b inhibitorji
US8129367B2 (en) * 2007-11-21 2012-03-06 Bristol-Myers Squibb Company Compounds for the treatment of Hepatitis C
US8124601B2 (en) 2007-11-21 2012-02-28 Bristol-Myers Squibb Company Compounds for the treatment of Hepatitis C
CN101903351B (zh) 2007-12-19 2014-09-10 贝林格尔.英格海姆国际有限公司 病毒聚合酶抑制剂
DK2238142T3 (da) * 2007-12-24 2012-10-08 Janssen R & D Ireland Makrocykliske indoler som hepatitis C-virusinhibitorer
JP2011515486A (ja) * 2008-03-27 2011-05-19 ブリストル−マイヤーズ スクイブ カンパニー Ｃ型肝炎の治療用化合物
CN101981038B (zh) * 2008-03-27 2013-07-10 百时美施贵宝公司 二氧戊环和二氧戊环酮稠合的吲哚并苯并二氮杂*hcv ns5b抑制剂
ES2416062T3 (es) * 2008-03-27 2013-07-30 Bristol-Myers Squibb Company Inhibidores de NS5B del VHC de indolobenzadiazepina condensados con pirrolidina
US8133884B2 (en) * 2008-05-06 2012-03-13 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
TWI454476B (zh) * 2008-07-08 2014-10-01 Tibotec Pharm Ltd 用作ｃ型肝炎病毒抑制劑之巨環吲哚衍生物
UY32099A (es) 2008-09-11 2010-04-30 Enanta Pharm Inc Inhibidores macrocíclicos de serina proteasas de hepatitis c
MX2011007195A (es) 2009-01-07 2013-07-12 Scynexis Inc Derivado de ciclosporina para el uso en el tratamiento de infección de virus de hepatitis c (vhc) y virus de inmunodeficiencia humana (vih).
US8143244B2 (en) * 2009-02-26 2012-03-27 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
AU2011268922B2 (en) 2010-06-24 2014-06-12 Janssen Sciences Ireland Uc Preparation of 13-cyclohexyl-3-methoxy-6-[methyl-(2-{2-[methyl-(sulphamoyl)-amino]-ethoxy}-ethyl)-carbamoyl]-7H-indolo-[2,1-a]-[2]-benzazepine-10-carboxylic acid
US20120196794A1 (en) * 2010-08-06 2012-08-02 Bristol-Myers Squibb Company Combinations of Hepatitis C Virus Inhibitors
US9173887B2 (en) 2010-12-22 2015-11-03 Abbvie Inc. Hepatitis C inhibitors and uses thereof
US8937041B2 (en) 2010-12-30 2015-01-20 Abbvie, Inc. Macrocyclic hepatitis C serine protease inhibitors
BR112013016480A2 (pt) 2010-12-30 2016-09-20 Abbvie Inc macrocíclo da fenantridina inibadores da protease da serina da hepatite c
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
US8716275B2 (en) * 2011-10-20 2014-05-06 Bristol-Myers Squibb Company Compound for the treatment of hepatitis C
EA025391B1 (ru) * 2012-07-18 2016-12-30 Бристол-Майерс Сквибб Холдингс Айеленд НОВЫЕ СПОСОБЫ И ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ ДЛЯ ПОЛУЧЕНИЯ (4bS,5aR)-12-ЦИКЛОГЕКСИЛ-N-(N,N-ДИМЕТИЛСУЛЬФАМОИЛ)-3-МЕТОКСИ-5a-((1R,5S)-3-МЕТИЛ-3,8-ДИАЗАБИЦИКЛО[3.2.1]ОКТАН-8-КАРБОНИЛ)-4b,5,5a,6-ТЕТРАГИДРОБЕНЗО[3,4]ЦИКЛОПРОПА[5,6]АЗЕПИНО[1,2-a]ИНДОЛ-9-КАРБОКСАМИДА
EP3089757A1 (en) 2014-01-03 2016-11-09 AbbVie Inc. Solid antiviral dosage forms

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US753137A (en) * 1904-02-23 Dust-pan
US752354A (en) * 1904-02-16 Composition post
US756203A (en) * 1903-11-14 1904-04-05 Oliver E Barthel Muffler.
RS50815B (sr) 2004-02-24 2010-08-31 Japan Tobacco Inc. Kondenzovana heterotetraciklična jedinjenja i njihova upotreba kao inhibitora hcv polimeraza
US7153848B2 (en) * 2004-08-09 2006-12-26 Bristol-Myers Squibb Company Inhibitors of HCV replication
US7348425B2 (en) * 2004-08-09 2008-03-25 Bristol-Myers Squibb Company Inhibitors of HCV replication
ATE384723T1 (de) 2004-10-13 2008-02-15 Merck Patent Gmbh Als kinaseinhibitoren geeignete derivate des n,n'-diphenylharnstoffs
AU2005298412B2 (en) * 2004-10-26 2011-06-09 Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa Tetracyclic indole derivatives as antiviral agents
GB0518390D0 (en) 2005-09-09 2005-10-19 Angeletti P Ist Richerche Bio Therapeutic compounds
US7399758B2 (en) * 2005-09-12 2008-07-15 Meanwell Nicholas A Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
US7473688B2 (en) * 2005-09-13 2009-01-06 Bristol-Myers Squibb Company Indolobenzazepine HCV NS5B inhibitors
US7456165B2 (en) * 2006-02-08 2008-11-25 Bristol-Myers Squibb Company HCV NS5B inhibitors
GB0608928D0 (en) * 2006-05-08 2006-06-14 Angeletti P Ist Richerche Bio Therapeutic agents

Also Published As

Publication number Publication date
AR061008A1 (es) 2008-07-30
EA015286B1 (ru) 2011-06-30
DK2024375T3 (da) 2011-06-27
AU2007253998B2 (en) 2012-03-15
AU2007253998A1 (en) 2007-11-29
IL195025A (en) 2013-09-30
KR20090008344A (ko) 2009-01-21
EP2024375B1 (en) 2011-03-09
CA2651690A1 (en) 2007-11-29
IL195025A0 (en) 2009-08-03
NZ572555A (en) 2010-11-26
SI2024375T1 (sl) 2011-10-28
TWI401244B (zh) 2013-07-11
JP5284952B2 (ja) 2013-09-11
HK1122814A1 (en) 2009-05-29
MX2008014435A (es) 2008-11-27
CY1111526T1 (el) 2016-02-10
JP2009537557A (ja) 2009-10-29
NO341663B1 (no) 2017-12-18
ATE501156T1 (de) 2011-03-15
EA200802346A1 (ru) 2009-06-30
TW200804282A (en) 2008-01-16
CA2651690C (en) 2014-11-04
ZA200809548B (en) 2009-12-30
HRP20110194T1 (hr) 2011-04-30
US7456166B2 (en) 2008-11-25
WO2007136982A1 (en) 2007-11-29
KR101417145B1 (ko) 2014-07-08
PL2024375T3 (pl) 2011-07-29
NO20084637L (no) 2008-12-15
DE602007013036D1 (de) 2011-04-21
BRPI0711821A2 (pt) 2012-01-17
EP2024375A1 (en) 2009-02-18
US20070270405A1 (en) 2007-11-22

Similar Documents

Publication Publication Date Title
PE20080070A1 (es) Derivados de indolobenzazepina fusionados a ciclopropilo como inhibidores de la polimerasa ns5b del virus de la hepatitis c
PE20090648A1 (es) Compuestos para el tratamiento de la hepatitis c
PE20080704A1 (es) Inhibidores ns5b del virus hepatitis c de indolobenzazepina fusionados a ciclopropilo
BR112013007696A2 (pt) composto, composição farmacêutica, usos do referido composto e da referida composição
MX2010008699A (es) Derivados heterociclicos como inhibidores de virus de la hepatitis c.
EA201791776A1 (ru) Замещенные циклофаны для использования при лечении инфекции вгс
MA37712A2 (fr) Inhibiteurs macrocycliques de virus flaviviridae
MX2010008749A (es) Inhibidores del virus de la hepatitis c.
PE20090511A1 (es) Imidazopiridinonas
EA200900298A1 (ru) Ингибиторы вируса гепатита с
ZA200900935B (en) Hepatitis C virus inhibitors
PE20070676A1 (es) Inhibidores ns5b de vhc de indolobenzazepina fusionados a ciclopropilo
EA201390822A1 (ru) Макроциклические ингибиторы вирусов flaviviridae
DK2250163T3 (da) Hepatitis C-virusinhibitorer
EA200870164A1 (ru) Лечение вирусного гепатита
NZ595186A (en) Di-pyrazolidinyl-biphenylyl compounds for treating hepatitis C virus (HCV) infection
EA201290575A1 (ru) Ингибиторы вирусов flaviviridae
EA201270656A1 (ru) Ингибиторы вируса гепатита с
TN2012000214A1 (en) Hepatitis c virus inhibitors
MX2011008045A (es) Inhibidores del virus de la hepatitis c.
PE20091103A1 (es) Inhibidores de la polimerasa virica
EA201201031A1 (ru) Ингибиторы вируса гепатита с
PE20070983A1 (es) COMPUESTOS DERIVADOS DE 3-DESAZAPURINA COMO AGONISTAS DEL RECEPTOR Toll-LIKE (TLR7)
MX2010008531A (es) Derivados de bifenilo conformacionalmente restringido para uso como inhibidores del virus de la hepatitis c.
EA201290576A1 (ru) Ингибиторы вирусов flaviviridae

Legal Events

Date Code Title Description
FG Grant, registration